Fontan Fitness Trial
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Children's Hospital of Philadelphia
- Study ID
- NCT06918795
- Status
- Recruiting
Conditions
- Congenital Heart Disease
- Single-ventricle
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Digital Exercise Intervention — BEHAVIORALSubjects randomized to the intervention arm will receive the same as the enhanced usual care arm but will be additionally exposed to: (1) personalized plans for aerobic-based PA, (2) personalized resistance exercise sessions, and (3) financial and non-financial engagement strategies. These intervention components will be delivered continuously using an advanced digital health informatics platform during the 6 months of the intervention. The intervention will be overseen and supplemented by the exercise physiologist, who will meet with participants on a weekly, then biweekly and finally monthly basis over 6 months.
Study Details
The goal of this randomized control trial is to learn about physical fitness and exercise habits in children aged 10-17 with the Fontan Circulation through a home-based, digital exercise intervention. The main questions it aims to answer are: * Does a home-based, digital intervention increase physical activity (PA) in youth with the FC compared to enhanced usual care? * Does a home-based, digital intervention increase physical fitness in youth with the FC compared to enhanced usual care? * Do multi-level factors (medical, neurodevelopmental, sociodemographic, neighborhood) impact the effectiveness of the digital intervention? Researchers will compare participants in the enhanced usual care arm to those in the exercise intervention arm to see if the digital intervention is effective. All participants will wear a PA tracker for 12 months and complete testing at baseline, 6 months, and 12 months. In addition, participants in the exercise intervention arm will complete a 6-month exercise intervention with the following components: * aerobic exercise * resistance exercise * engagement strategies
Key Dates
- Start date
- Jun 9, 2025
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2029
- Completion
- Apr 30, 2029
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Digital Exercise InterventionThe exercise intervention arm includes access to a digital application to receive the following over the 6-month intervention: * personalized plans for aerobic-based PA * personalized resistance exercise sessions * engagement strategies.
- No Intervention: Enhanced Usual CareThe enhanced usual care arm will receive their usual care in addition to a passive physical activity tracker device. No intervention materials will be delivered to these participants over the course of their enrollment in the study.
Primary Outcome Measure
MIMS-units [ Time Frame: 0 to 12 months. Evaluated from baseline to 6 months, baseline to 12 months, and 6 to 12 months. ]
Central Contacts
- Elizabeth Goldmuntz, MD215-590-3354
- Zoe Lincoln, MS
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Elizabeth Goldmuntz, MD Zoe Lincoln, MS Elizabeth Goldmuntz, MD (PRINCIPAL_INVESTIGATOR) Jonathan Mitchell, PhD (SUB_INVESTIGATOR) |
Find similar trials in Philadelphia, PA
Related Studies
- Fibrosis and the FontanPHASE1/PHASE2 · Recruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- EXCOR Active Driving System for the EXCOR Pediatric VAD IDE StudyEnrolling By Invitation · Berlin Heart, Inc · Los Angeles, California
- Molecular and Cellular Characterization of Cardiac Tissue in Postnatal DevelopmentRecruiting · Emory University · Atlanta, Georgia
- Genetics of Congenital Heart DiseaseRecruiting · Nationwide Children's Hospital · Columbus, Ohio